It is expected that a price bounce should occur soon.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 54 cases where EVCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +1.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVCM advanced for three days, in 212 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
EVCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 132 of 191 cases where EVCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EVCM as a result. In 62 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for EVCM turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 27 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.
EVCM moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for EVCM crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. EVCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.030) is normal, around the industry mean (-1.906). P/E Ratio (41.100) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.417) is also within normal values, averaging (70.383).
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PRVA moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on PRVA as a result. In 58 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for PRVA just turned positive on November 05, 2026. Looking at past instances where PRVA's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
The 10-day moving average for PRVA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRVA advanced for three days, in 196 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 139 of 211 cases where PRVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
PRVA broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PRVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.987) is normal, around the industry mean (4.477). PRVA's P/E Ratio (106.174) is considerably higher than the industry average of (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.127) is also within normal values, averaging (6.065).
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
| EVCM | PRVA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 2 days ago 74% |
| Stochastic ODDS (%) | 1 day ago 72% | 2 days ago 80% |
| Momentum ODDS (%) | 1 day ago 76% | 2 days ago 66% |
| MACD ODDS (%) | 1 day ago 64% | 2 days ago 73% |
| TrendWeek ODDS (%) | 1 day ago 80% | 2 days ago 72% |
| TrendMonth ODDS (%) | 1 day ago 77% | 2 days ago 69% |
| Advances ODDS (%) | 21 days ago 70% | 3 days ago 72% |
| Declines ODDS (%) | 1 day ago 81% | 10 days ago 76% |
| BollingerBands ODDS (%) | 1 day ago 80% | 2 days ago 79% |
| Aroon ODDS (%) | 1 day ago 69% | 2 days ago 66% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVCM’s FA Score shows that 0 FA rating(s) are green while PRVA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVCM’s TA Score shows that 5 TA indicator(s) are bullish while PRVA’s TA Score has 6 bullish TA indicator(s).
EVCM (@Packaged Software) experienced а -15.69% price change this week, while PRVA (@Services to the Health Industry) price change was +13.51% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -2.44%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +4.03%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.21%. For the same industry, the average monthly price growth was +2.13%, and the average quarterly price growth was +27.96%.
EVCM is expected to report earnings on Mar 18, 2027.
PRVA is expected to report earnings on Mar 02, 2027.
Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (+0.21% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
A.I.dvisor indicates that over the last year, EVCM has been loosely correlated with LYFT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EVCM jumps, then LYFT could also see price increases.
| Ticker / NAME | Correlation To EVCM | 1D Price Change % | ||
|---|---|---|---|---|
| EVCM | 100% | -2.27% | ||
| LYFT - EVCM | 53% Loosely correlated | +1.59% | ||
| PLUS - EVCM | 52% Loosely correlated | +0.60% | ||
| ALIT - EVCM | 52% Loosely correlated | +0.08% | ||
| WEAV - EVCM | 50% Loosely correlated | N/A | ||
| FSLY - EVCM | 48% Loosely correlated | +6.28% | ||
More | ||||
A.I.dvisor indicates that over the last year, PRVA has been loosely correlated with RIOT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRVA jumps, then RIOT could also see price increases.
| Ticker / NAME | Correlation To PRVA | 1D Price Change % | ||
|---|---|---|---|---|
| PRVA | 100% | -0.69% | ||
| RIOT - PRVA | 46% Loosely correlated | +2.38% | ||
| EVCM - PRVA | 45% Loosely correlated | -13.30% | ||
| EVTC - PRVA | 45% Loosely correlated | -0.87% | ||
| SPT - PRVA | 45% Loosely correlated | +0.18% | ||
| QLYS - PRVA | 45% Loosely correlated | -13.51% | ||
More | ||||